These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 30518811)

  • 1. Depletion of Ars2 inhibits cell proliferation and leukemogenesis in acute myeloid leukemia by modulating the miR-6734-3p/p27 axis.
    Hu X; Xu S; Chen Y; Gao Z; Li Y; Hu J; Huang X; Zhang Y; Jiang X; Li L; Yang C; Chen J; Gao N
    Leukemia; 2019 May; 33(5):1090-1101. PubMed ID: 30518811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ars2 promotes cell proliferation and tumorigenicity in glioblastoma through regulating miR-6798-3p.
    Chen Y; Hu X; Li Y; Zhang H; Fu R; Liu Y; Hu J; Deng Q; Luo Q; Zhang D; Gao N; Cui H
    Sci Rep; 2018 Oct; 8(1):15602. PubMed ID: 30349053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-582-3p negatively regulates cell proliferation and cell cycle progression in acute myeloid leukemia by targeting cyclin B2.
    Li H; Tian X; Wang P; Huang M; Xu R; Nie T
    Cell Mol Biol Lett; 2019; 24():66. PubMed ID: 31844417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p27kip1 maintains a subset of leukemia stem cells in the quiescent state in murine MLL-leukemia.
    Zhang J; Seet CS; Sun C; Li J; You D; Volk A; Breslin P; Li X; Wei W; Qian Z; Zeleznik-Le NJ; Zhang Z; Zhang J
    Mol Oncol; 2013 Dec; 7(6):1069-82. PubMed ID: 23988911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel miR-375-HOXB3-CDCA3/DNMT3B regulatory circuitry contributes to leukemogenesis in acute myeloid leukemia.
    Bi L; Zhou B; Li H; He L; Wang C; Wang Z; Zhu L; Chen M; Gao S
    BMC Cancer; 2018 Feb; 18(1):182. PubMed ID: 29439669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-192 regulates cell proliferation and cell cycle transition in acute myeloid leukemia via interaction with CCNT2.
    Ke S; Li RC; Lu J; Meng FK; Feng YK; Fang MH
    Int J Hematol; 2017 Aug; 106(2):258-265. PubMed ID: 28409330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functionally distinct roles for different miR-155 expression levels through contrasting effects on gene expression, in acute myeloid leukaemia.
    Narayan N; Morenos L; Phipson B; Willis SN; Brumatti G; Eggers S; Lalaoui N; Brown LM; Kosasih HJ; Bartolo RC; Zhou L; Catchpoole D; Saffery R; Oshlack A; Goodall GJ; Ekert PG
    Leukemia; 2017 Apr; 31(4):808-820. PubMed ID: 27740637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-183 promotes cell proliferation via regulating programmed cell death 6 in pediatric acute myeloid leukemia.
    Wang X; Zuo D; Yuan Y; Yang X; Hong Z; Zhang R
    J Cancer Res Clin Oncol; 2017 Jan; 143(1):169-180. PubMed ID: 27738758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ars2 links the nuclear cap-binding complex to RNA interference and cell proliferation.
    Gruber JJ; Zatechka DS; Sabin LR; Yong J; Lum JJ; Kong M; Zong WX; Zhang Z; Lau CK; Rawlings J; Cherry S; Ihle JN; Dreyfuss G; Thompson CB
    Cell; 2009 Jul; 138(2):328-39. PubMed ID: 19632182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-20a-5p functions as a potent tumor suppressor by targeting PPP6C in acute myeloid leukemia.
    Bao F; Zhang L; Pei X; Lian C; Liu Y; Tan H; Lei P
    PLoS One; 2021; 16(9):e0256995. PubMed ID: 34587164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of LIN28B impairs leukemia cell growth and metabolism in acute myeloid leukemia.
    Zhou J; Bi C; Ching YQ; Chooi JY; Lu X; Quah JY; Toh SH; Chan ZL; Tan TZ; Chong PS; Chng WJ
    J Hematol Oncol; 2017 Jul; 10(1):138. PubMed ID: 28693523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circular RNA circCRKL inhibits the proliferation of acute myeloid leukemia cells via the miR-196a-5p/miR-196b-5p/p27 axis.
    Liu W; Cheng F
    Bioengineered; 2021 Dec; 12(1):7704-7713. PubMed ID: 34617876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of miR-504-3p is associated with favorable prognosis of acute myeloid leukemia and may serve as a tumor suppressor by targeting MTHFD2.
    Li SM; Zhao YQ; Hao YL; Liang YY
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1203-1213. PubMed ID: 30779090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small extracellular vesicles derived from acute myeloid leukemia cells promote leukemogenesis by transferring miR-221-3p.
    Li M; Sun G; Zhao J; Pu S; Lv Y; Wang Y; Li Y; Zhao X; Wang Y; Yang S; Cheng T; Cheng H
    Haematologica; 2024 Oct; 109(10):3209-3221. PubMed ID: 38450521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-34b Targets HSF1 to Suppress Cell Survival in Acute Myeloid Leukemia.
    Li G; Song Y; Zhang Y; Wang H; Xie J
    Oncol Res; 2016; 24(2):109-16. PubMed ID: 27296951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-9 promotes proliferation of leukemia cells in adult CD34-positive acute myeloid leukemia with normal karyotype by downregulation of Hes1.
    Tian C; You MJ; Yu Y; Zhu L; Zheng G; Zhang Y
    Tumour Biol; 2016 Jun; 37(6):7461-71. PubMed ID: 26678889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA LINC00899 promotes progression of acute myeloid leukaemia by modulating miR-744-3p/YY1 signalling.
    Dong X; Xu X; Guan Y
    Cell Biochem Funct; 2020 Oct; 38(7):955-964. PubMed ID: 32157707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-152-3p promotes the development of chronic myeloid leukemia by inhibiting p27.
    Wang L; Wang Y; Lin J
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8789-8796. PubMed ID: 30575920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-638 regulates differentiation and proliferation in leukemic cells by targeting cyclin-dependent kinase 2.
    Lin Y; Li D; Liang Q; Liu S; Zuo X; Li L; Sun X; Li W; Guo M; Huang Z
    J Biol Chem; 2015 Jan; 290(3):1818-28. PubMed ID: 25451924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-196b target screen reveals mechanisms maintaining leukemia stemness with therapeutic potential.
    Meyer SE; Muench DE; Rogers AM; Newkold TJ; Orr E; O'Brien E; Perentesis JP; Doench JG; Lal A; Morris PJ; Thomas CJ; Lieberman J; McGlinn E; Aronow BJ; Salomonis N; Grimes HL
    J Exp Med; 2018 Aug; 215(8):2115-2136. PubMed ID: 29997117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.